ghk-cu study news 2025 GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration 6 month GHK-CU check-in Main

They help figure out if the dose is working and if it needs to be changed

A small number of people are reporting a delayed arm rash about a week after receiving the COVID-19 vaccine, most commonly after the first dose

0.28 g of NaHS (Sigma-Aldrich )

Oral delivery is pharmacokinetically disadvantaged versus injection for systemic targets, but may have a genuine local advantage for GI-tract applications because degradation products act locally before absorption

Research updates, peptide guides, and science-backed insights to help you understand how peptides work and what the evidence says

We thank Mathieu Blanchette for the helpful comments on the paper